IRIS
CUTOLO, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 65.299
Totale 65.299
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 65.299
Totale 65.299
Salva come PNG Salva come JPEG
Città #
Genova 49.232
Genoa 5.567
Rapallo 5.497
Vado Ligure 4.846
Bordighera 157
Totale 65.299
Salva come PNG Salva come JPEG
Nome #
Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. 519
1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. 194
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 166
The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases 158
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. 157
Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal 156
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 156
Androgens in rheumatoid arthritis: when are they effectors? 150
Cross-cultural adaptation and validity of the Italian version of the Central Sensitization Inventory 149
Steroids and Autoimmunity 148
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 148
Zinc concentrations in rheumatoid and psoriatic arthritis. Are they relevant to the inflammatory process? 147
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 145
Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms. 144
Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. 142
Functional study of glenohumeral ligaments. 141
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 141
Evolutionary medicine and bone loss in chronic inflammatory diseases-A theory of inflammation-related osteopenia 140
The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. 139
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 139
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 139
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production. 138
Rheumatoid arthritis: circadian and circannual rhythms in RA. 138
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. 137
Special issue on glucocorticoid therapy in rheumatic diseases: introduction 137
Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines 137
Atlas of Capillaroscopy in Rheumatic Diseases 136
Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis 136
Early and repeated IgG1Fc-pCons chimera vaccinations (GX101) improve the outcome in SLE-prone mice 134
Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis 134
The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. 133
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO). 133
[CTLA4-Ig interferes and downregulates the proinflammatory activities of rheumatoid synovial macrophages in monoculture] 132
Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. 131
Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study. 131
Pregnancy, cytokines and disease activity in systemic lupus erythematosus 131
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. 131
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 130
Timing of transition between capillaroscopic patterns in systemic sclerosis. 130
Modulation of cell growth and apoptosis by sex hormones in cultured monocytic THP-1 cells. 129
Systemic sclerosis: state of the art on clinical practice guidelines 129
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. 128
Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. 128
Acral localized acquired cutis laxa associated with rheumatoid arthritis. 128
Therapy. Optimized treatment algorithms for digital vasculopathy in SSc. 128
Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS). 128
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients 128
Nocturnal hormones and clinical rhythms in rheumatoid arthritis. 127
Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. 127
Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. 127
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern 127
Vitamin D endocrine system involvement in autoimmune rheumatic diseases 127
Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. 126
Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis 126
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 126
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 126
Air Travel, Circadian Rhythms/Hormones, and Autoimmunity. 125
Lack of sialic acid in synovial fluid fibronectin. 124
Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study 124
Vitamin D endocrine system and the immune response in rheumatic diseases. 123
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis 123
Indoleamine 2,3 dioxygenase gene polymorphisms correlate with CD8+ Treg impairment in systemic sclerosis. 123
An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases 123
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 123
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 123
Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional? 123
Androgen replacement therapy in male patients with rheumatoid arthritis. 122
Evidence for increase in finger blood flow, evaluated by laser Doppler flowmetry, following iloprost infusion in patients with systemic sclerosis: a week-long observational longitudinal study 122
Estrogen's effects in chronic autoimmune/inflammatory diseases and progression to cancer 121
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 121
Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA to measure peripheral blood perfusion in scleroderma patients. 121
The controversy over zinc sulphate efficacy in rheumatoid and psoriatic arthritis. 120
Rapid interaction between CTLA4-Ig (abatacept) and synovial macrophages from patients with rheumatoid arthritis. 120
Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients 120
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 119
Nail involvement in osteoarthritis. 119
2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis 119
Immunomodulatory mechanisms mediated by sex hormones in rheumatoid arthritis. 118
Phorbol diester 12-O-tetradecanoylphorbol 13-acetate (TPA) up-regulates the expression of estrogen receptors in human THP-1 leukemia cells. 118
Interspinous bursitis is common in polymyalgia rheumatica, but is not associated with spinal pain 118
There is a need for new systemic sclerosis subset criteria. A content analytic approach 118
Introduction: new trends in pregnancy and rheumatic diseases. 118
Dissecting the inflammatory response in polymyalgia rheumatica: the relative role of IL-6 and its inhibition 118
Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. 117
Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis. 117
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis. 117
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients. 117
Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. 116
Androgen metabolism and inhibition of interleukin-1 synthesis in primary cultured human synovial macrophages. 116
Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus. 116
Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis 116
Quantitative outcome measures for systemic sclerosis-related Microangiopathy - Reliability of image acquisition in Nailfold Capillaroscopy. 116
Hypocupremia-related hypochromic anemia during D-penicillamine treatment. 116
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3. 116
Ehlers-Danlos syndromes: state of the art on clinical practice guidelines. 116
Estrogens in pregnancy and systemic lupus erythematosus. 115
Review: vitamin D, immunity and lupus. 115
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 115
Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis 115
Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside. 115
Totale 13.329
Salva come PNG Salva come JPEG
Categoria #
all - tutte 194.420
article - articoli 184.527
book - libri 0
conference - conferenze 7.193
curatela - curatele 248
other - altro 153
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.299
Totale 388.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014.102 0 0 0 0 0 1.921 2.959 1.399 1.743 3.269 2.071 740
2020/20215.401 313 396 872 368 378 467 276 416 567 552 387 409
2021/20228.378 239 593 656 959 201 481 581 2.043 473 795 323 1.034
2022/20236.782 806 249 50 569 1.237 1.159 47 662 1.194 61 660 88
2023/20244.131 187 657 83 378 299 647 258 343 192 80 238 769
2024/20255.462 428 1.107 408 744 1.672 1.103 0 0 0 0 0 0
Totale 67.146